ArticleInsights into imaging2026
The accuracy of spectral CT with quantitative parameters in differentiating septic from aseptic periprosthetic complications.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo explore the accuracy of spectral CT, using quantitative parameters, in differentiating septic from aseptic periprosthetic complications. MATERIALS AND
methodsThis study consecutively included patients with clinically suspected periprosthetic complications who underwent preoperative spectral CT and planned revision surgery between September 2020 and June 2024. Spectral quantitative parameters, including iodine concentration (IC), effective atomic number (Zeff), and normalized iodine concentration (NIC) on arterial and venous phases (AP, VP) for periprosthetic bone and soft tissue lesions were measured. Qualitative assessment of periprosthetic joint infection (PJI) was conducted by reviewing spectral CT images. The diagnostic performance of quantitative parameters for PJI was evaluated and compared to qualitative assessment.
resultsA total of 59 patients with 62 prostheses (mean age ± SD, 67.20 years ± 12.12; 26 men; septic group: aseptic group 26: 36 prostheses) were included. The IC-AP values were significantly higher in the septic group compared to the aseptic group across integrated and separate analyses of bone and soft tissue lesions (1.25 ± 0.59 vs. 0.50 ± 0.36; 1.58 ± 0.74 vs. 0.53 ± 0.37; and 1.10 ± 0.43 vs. 0.43 ± 0.32, respectively; all p < 0.001). IC-AP showed the highest diagnostic accuracy, with values of 84.3% (integrated), 90.7% (bone), and 89.6% (soft tissue). Other parameters also showed significant differences (all p ≤ 0.012) and good diagnostic performance. The diagnostic accuracy of qualitative assessment by the senior and junior radiologists, based on CT imaging features of PJI, was 82.3% and 75.8%, respectively.
conclusionsSpectral CT with quantitative parameters has the potential to improve the differentiation between septic and aseptic periprosthetic complications. CRITICAL RELEVANCE STATEMENT: Spectral CT may offer quantitative imaging biomarkers with the potential to improve visualization and identification of periprosthetic joint infections, particularly in complex cases and among less-experienced radiologists, thereby facilitating the clinical decision-making process. KEY POINTS: Accurate diagnosis of periprosthetic joint infection is crucial for treatment decisions. Quantitative parameters of spectral CT showed significant increases and high diagnostic accuracy in identifying septic periprosthetic complications. Spectral CT with quantitative parameters may serve as an imaging biomarker to enhance the clinical decision-making process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.